Caapi Research Articles

Influence of Environmental Factors and Cultural Methods on the Content of N,N‑Dimethyltryptamine in Psychotria viridis (Rubiaceae)

Psychotria viridis is one of the species that produces N,N-dimethyltryptamine. Its decoction together with other species, such as Banisteriopsis caapi, produces ayahuasca, a beverage used for ritualistic and medicinal purposes. The goal of this study was to understand how environmental factors and cultivation methods influenced the content of N,N-dimethyltryptamine in P. viridis. Over all four seasons, leaf samples were collected from 25 different locations in 14 Brazilian states, and Federal District. Environmental parameters, micro and macronutrients, plant characteristics, information on farming methods were correlated with N,N-dimethyltryptamine content, determined by gas chromatography coupled to mass spectrometry (GC-MS). Greatest effects on the N,N-dimethyltryptamine amount were associated with seasonality, altitude, latitude and biome type. A positive correlation between N and Mg content and N,N-dimethyltryptamine levels was statistically established. By regression analysis, the adequate foliar nutrient levels that would result in the concentration of N,N-dimethyltryptamine in cultivated plants similar to that of Amazonian P. viridis were equated.

Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice.

The Quechua term ayahuasca refers to a beverage obtained from decoctions of the liana Banisteriopsis caapi with leaves of Psychotria viridis. The ritualistic use of ayahuasca is becoming a global phenomenon, with some individuals using this beverage throughout life, including in old age. Cognitive impairment is a common manifestation during aging. There are conflicting reports on the ability of some ayahuasca compounds to exert neuroprotective or neurotoxic effects that could improve or impair learning and memory. Animal models provide a relevant and accessible means of investigating the behavioral effects of ayahuasca without the environmental conditions associated with the ritualistic use of the beverage. In this study, we investigated the influence of chronic ayahuasca exposure throughout aging on the spatial reference and habituation memories of mice. Twenty-eight male c57bl/6 mice (6 months old) received ayahuasca or water (1.5 mL/kg, orally) twice a week for 12 months and were tested in the Morris water maze (MWM), open field and elevated plus maze (EPM) tasks before and after treatment. During aging, there was significant impairment in the evocation (but not acquisition) of spatial reference memory and in habituation to the open field. There was also a decrease in locomotor activity in the open field and EPM tests, whereas the anxiety parameters were unaltered. Ayahuasca treatment did not alter any of these parameters associated with aging. These findings indicate that chronic exposure to ayahuasca during aging did not affect memory in mice.

An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.

Ayahuasca is a beverage obtained from decoctions of the Banisteriopsis caapi plus Psychotria viridis. In religious contexts, ayahuasca is used by different age groups. However, little is known of the effects of ayahuasca during ontogenic development, particularly with regard to the functional characteristics of the central nervous system. Animal models are useful for studying the ontogenic effects of ayahuasca because they allow exclusion of the behavioral influence associated with the ritualistic use. We investigated the effects of exposure to ayahuasca (1.5 mL/kg, orally, twice a week) on memory and anxiety in C57BL/6 mice, with the post-natal day (PND) being used as the ontogenic criterion for classification: childhood (PND21 to PND35), adolescence (PND35 to PND63), adulthood (PND90-PND118), childhood-adolescence (PND21 to PND63), childhood-adulthood (PND21 to PND118) and adolescence-adulthood (PND35 to PND118). One day after the last ayahuasca exposure, the mice were subjected to the Morris water maze (MWM), open field and elevated plus maze tasks (EPM). Ayahuasca did not affect locomotion in the open field or open arms exploration in the EPM, but increased the risk assessment behavior in the childhood group. Ayahuasca did not cause any change in acquisition of spatial reference memory in the MWM task, but decreased the time spent on the platform quadrant during the test session in the adolescence group. These results suggest that, in mice, exposure to ayahuasca in childhood and adolescence promoted anxiety and memory impairment, respectively. However, these behavioral changes were not long-lasting since they were not observed in the childhood-adulthood and adolescence-adulthood groups.

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Ayahuasca is a traditional psychoactive sacrament that's been used in Amazonian shamanic rituals for hundreds of years. Ayahuasca is notorious for its psychedelic properties produced from the combination of monoamine oxidase inhibitors (MAOIs) found in the Banisteriopsis caapi vine and N-N-dimethyltryptamine from Psychotria viridis or Diplopterys cabrerana. Recently, ritual use of ayahuasca has increased and garnered attention for its potential in treating mental illnesses, such as substance use and depressive disorders. Due to its MAOI properties, there are serious drug interactions that may be of concern among patients who participate in ayahuasca use. The objectives of this paper are to describe ayahuasca's pharmacology, potential drug interactions, and clinical data for its treatment potential in psychiatric illness.

Efecto de la ingestión de Banisteriopsis caapi y Psychotria viridis ‘Binomio ayahuasca’ en el hipocampo del cerebro de ratas

Objetivo. Evaluar el efecto de la ingestión de Banisteriopsis caapi y Psychotria viridis ‘Binomio ayahuasca’ en el hipocampo de cerebro de ratas. Diseño. Estudio experimental, descriptivo, analítico, transversal. Institución. Instituto de Investigación en Ciencias Farmacéuticas y Recursos Naturales, Facultad de Farmacia y Bioquímica, Universidad Nacional Mayor de San Marcos, Lima, Perú. Material biológico. Ratas. Intervenciones. Administración del binomio ayahuasca por vía orogástrica a ratas albinas adultas de la especie Rattus novergicus y de cepa Holtzman. A siete grupos de cinco con un peso promedio de 240 ± 30 g se les administró: (GI) blanco, (GII) 2,5 mL diazepam, (GIII) 0,7 mL solución de Banisteriopsis caapi, (GIV) 0,7 mL Psychotria viridis, y a los grupos (GV), (GVI) y (GVII) se administró 0,7 mL, 3,5 mL y 7,0 mL de solución del binomio ayahuasca, respectivamente. Principales medidas de resultados. Macroscópicos: comportamiento de reflejos y actividad motora. Microscópicos: número de células piramidales y granulosas, y desorganización celular. Resultados. En el tamizaje fitoquímico del extracto se caracterizó presencia de alcaloides, antraquinonas, triterpenoides y esteroides, fenoles, flavonoides y saponinas. Los volúmenes de droga administradas a los grupos de intervención con el binomio en la dosis de 0,7 mL manifestaron significativo aumento en el número de células granulosas sobre las células piramidales; a dosis de 3,5 mL el número de células granulosas fue menor con presencia de células piramidales grandes y pequeñas; y a dosis de 7,0 mL se manifestó desorganización celular, presencia de células piramidales grandes y pequeñas, y aumento de células granulosas. Conclusiones. El extracto alcohólico del binomio ayahuasca presenta efecto neuropatológico en el hipocampo del cerebro de ratas.

Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies

ABSTRACTHarmine is a natural β-carboline alkaloid found in several botanical species, such as the Banisteriopsis caapi vine used in the preparation of the hallucinogenic beverage ayahuasca and the seeds of Syrian rue (Peganum harmala). Preclinical studies suggest that harmine may have neuroprotective and cognitive-enhancing effects, and retrospective/observational investigations of the mental health of long-term ayahuasca users suggest that prolonged use of this harmine-rich hallucinogen is associated with better neuropsychological functioning. Thus, in order to better investigate these possibilities, we performed a systematic literature review of preclinical studies analyzing the effects of harmine on hippocampal neurons and in memory-related behavioral tasks in animal models. We found two studies involving hippocampal cell cultures and nine studies using animal models. Harmine administration was associated with neuroprotective effects such as reduced excitotoxicity, inflammation, and oxidative stress, and increased brain-derived neurotrophic factor (BDNF) levels. Harmine also improved memory/learning in several animal models. These effects seem be mediated by monoamine oxidase or acetylcholinesterase inhibition, upregulation of glutamate transporters, decreases in reactive oxygen species, increases in neurotrophic factors, and anti-inflammatory effects. The neuroprotective and cognitive-enhancing effects of harmine should be further investigated in both preclinical and human studies.

Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.

Ayahuasca is a hallucinogenic plant preparation which usually contains the vine Banisteriopsis caapi and the shrub Psychotria viridis. This tea originates from the Amazon Basin where it is used in religious ceremonies. Because interest in these religious groups spreading as well as awareness of use of ayahuasca for therapeutic and recreational purposes, its use is increasing. Banisteriopsis caapi is rich in β-carbolines, especially harmine, tetrahydroharmine and harmaline, which have monoamine oxidase inhibiting (MAOI) activity. Psychotria viridis contains the 5HT2A/2C/1A receptor agonist hallucinogen N,N-dimethyltryptamine (DMT). Usual desired effects include hallucination, dissociation, mood alteration and perception change. Undesired findings previously reported are nausea, vomiting, hypertension, and tachycardia. All human exposure calls reported to the American Association of Poison Controls Centers' (AAPCC) National Poison Data System (NPDS) between September 1, 2005 and September 1, 2015 were reviewed. Cases were filtered for specific plant derived ayahuasca-related product codes. Abstracted data included the following: case age and gender, exposure reason, exposure route, clinical manifestations, treatments given, medical outcomes and fatality. Five hundred and thirty-eight exposures to ayahuasca botanical products were reported. The majority of the calls to poison control centers came from healthcare facilities (83%). The most common route of exposure was ingestion. Most cases were men (437, 81%, 95% CI 77.7% - 84.3%). The median age was 21 (IQR 18-29). Most exposures were acute. Three hundred thirty-seven (63%) were reported to have a major or moderate clinical effect. The most common clinical manifestations reported were hallucinations (35%), tachycardia (34%), agitation (34%), hypertension (16%), mydriasis (13%) and vomiting (6%). Benzodiazepines were commonly given (30%). There were 28 cases in the series who required endotracheal intubation (5%). Four cases were reported to have had a cardiac arrest and 7 a respiratory arrest. Twelve cases had a seizure. Reports of exposures called to poison centers appeared to increase during this period based on annual estimates. Three fatalities were reported. Ayahuasca use appears to be rising in the United States based on calls to poison control centers. While most use is reported to be safe and well tolerated, with possible beneficial effects, serious and life threatening adverse manifestations are possible. Most of the exposures reported to poison control centers were young people, more likely to be men and already in a healthcare facility. Further research, which includes comprehensive drug testing, will be needed to better identify the risks and effects of ayahuasca use.

Ayahuasca: Friend or Foe?

Back to table of contents Previous article Next article CommentaryNo AccessAyahuasca: Friend or Foe?Gerard I. Fernando, M.D.Gerard I. FernandoSearch for more papers by this author, M.D.Published Online:26 Apr 2017https://doi.org/10.1176/appi.ajp-rj.2016.110605AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail Ayahuasca is an entheogenic brew that is used as a medicinal sacrament and for ritualistic purposes among religious groups in South America. In the last decade, people from all walks of life, usually in their 20s and 30s, from North America and Europe have started to seek access to the substance. Many have traveled to South America, notably Brazil and Peru, to participate in the ayahuasca ritual.Once consumed, it induces hallucinations and spiritual experiences that are thought to be due to increased introspection. Effects begin about 30 minutes after consumption and can last up to 8 hours. Ayahuasca can contain the Banisteriopsis caapi vine alone, which contains monoamine oxidase A (MAO-A)-inhibiting beta-carbolines, but is often combined with Chacruna (Psychotria viridis) or Chagropanga leaves, which have high concentrations of the psychedelic compound N, N-dimethyltryptamine (DMT) (1). Alone, DMT is made inactive by intestinal MAO-A metabolism; therefore, it is combined with a monoamine oxidase inhibitor to allow absorption of the active substance. Once it crosses the blood-brain barrier, DMT acts as a 5-HT1A/2A/2C agonist and a mGluR2 agonist. There is increased blood flow to the frontal and paralimbic brain areas after ingestion, specifically bilateral activation of the anterior insula/inferior frontal gyrus, anterior cingulate/medial frontal gyrus in the right hemisphere, and amygdala/parahippocampal gyrus in the left hemisphere (2). These areas have previously been implicated in somatic awareness and emotional arousal. Compared with the better studied psychedelic lysergic acid diethylamide (LSD), the experience with ayahuasca is described as more intense, with people sometimes losing touch with their physical surroundings. Ayahuasca also causes vomiting (unlike LSD), which is considered to be an important part of the ritual.An explanation for the increase in popularity may be due to a recent spike in media coverage of ayahuasca. Celebrities—from the singer Sting to the actress Lindsay Lohan—along with major media outlets, such as the New York Times and Huffington Post, are singing the praises of ayahuasca, which may be contributing to the increase in its use and perceived safety. Furthermore, ayahuasca may show promise in the treatment of several psychiatric disorders. Studies have shown its effectiveness in treating depression (3) and addiction (4) in humans, although these were observational and limited in significance. In a CNN documentary hosted by journalist Lisa Ling, increasing use of the psychedelic in veteran populations was exposed. Ling followed veterans to South America, where they ingested ayahuasca in hopes of treating their PTSD symptoms. While popular culture has supported its expanding use, it can lead to significant medical complications, such as serotonin syndrome and death. An increasing number of deaths after intoxication have been reported and suspected to be the result of serotonin syndrome, as many of the affected individuals were medicated with selective serotonin reuptake inhibitors prior to taking ayahuasca (5).Due to an explosion of media coverage, our patients may become interested in ingesting ayahuasca in hopes of treating their psychiatric conditions. Warning them of the possible dangers, particularly serotonin syndrome, could potentially save their lives.Dr. Fernando is a fourth-year resident at Harvard South Shore, VA Boston Healthcare System, Psychiatry, Brockton, Mass.The author thanks Shalini Rao, Dilantha and Pushpini Fernando for their help in reviewing this commentary. The author also thanks Andrew Szanton for advising on this commentary.

Sintomatologia psicótica e ayahuasca: relato de caso

Hallucinogens are chemical agents that induce changes in perception, thinking, and emotions. One natural hallucinogen is ayahuasca, originally used in the Amazon by indigenous tribes, prepared as a mixture of two plants: Banisteriopsis caapi, which contains beta-carbolines, an inhibitor of monoamine oxidase (MAO), and Psychotria viridis, rich in N,N-dimethyltryptamine (DMT), which actson serotonergic receptors. Currently, the use of ayahuasca tea has spread to different regions of the world, and some religions, such as Brazilian denominations Uniao do Vegetal, Santo Daime, and Barquinha, use the tea in their rituals. This study reports on a case of psychotic symptoms and ayahuasca use. A young woman was admitted for social isolation, poor self-care, and bizarre delusions starting 3 years ago, with gradual worsening. She was a member of Uniao do Vegetal and made frequent use of ayahuasca. During hospitalization, she was diagnosed with schizophrenia, and improved after electroconvulsivetherapy. Recent research shows that clinical manifestations of hallucinogens resemble those of schizophrenia. Therefore, pharmacological experiments with hallucinogens are often used as models of psychosis.

The routes of a plant: ayahuasca and the global networks of Santo Daime

This paper examines the Santo Daime religion, the Amazonian town of Céu do Mapiá which is one of its primary spiritual centres, and Ayahuasca, a key sacrament of the Santo Daime religion. The small village in the Amazon demonstrates the active outreach by a place which functions as a nexus of international and intercontinental flows of substances, bodies and meanings. The power of place is entwined with the story of religious belief and practice, which in turn depends on a tropical vine, Banisteriopsis caapi. In this networking process, we find a confluence of human agency with more-than-human agency, as well as the modalities of religious experience, crossing and dwelling. It is demonstrated that religious networking can be understood in terms of three forms of crossing (terrestrial, corporeal and cosmic) held together by the power of place (Mapiá and other subsidiary spiritual centres). In addition, three aspects of the ‘ayahuasca network’ are treated in depth: religious diffusion and adaptation, interaction with environmental movements and ideologies and contestation with legal structures and processes surrounding international drug traffic and the use of psychoactive substances.

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans

Ayahuasca is an Amazonian psychotropic plant tea typically obtained from two plants, Banisteriopsis caapi and Psychotria viridis. It contains the psychedelic 5-HT2A and sigma-1 agonist N,N-dimethyltryptamine (DMT) plus β-carboline alkaloids with monoamine-oxidase (MAO)-inhibiting properties. Although the psychoactive effects of ayahuasca have commonly been attributed solely to agonism at the 5-HT2A receptor, the molecular target of classical psychedelics, this has not been tested experimentally. Here we wished to study the contribution of the 5-HT2A receptor to the neurophysiological and psychological effects of ayahuasca in humans. We measured drug-induced changes in spontaneous brain oscillations and subjective effects in a double-blind randomized placebo-controlled study involving the oral administration of ayahuasca (0.75mg DMT/kg body weight) and the 5-HT2A antagonist ketanserin (40mg). Twelve healthy, experienced psychedelic users (5 females) participated in four experimental sessions in which they received the following drug combinations: placebo+placebo, placebo+ayahuasca, ketanserin+placebo and ketanserin+ayahuasca. Ayahuasca induced EEG power decreases in the delta, theta and alpha frequency bands. Current density in alpha-band oscillations in parietal and occipital cortex was inversely correlated with the intensity of visual imagery induced by ayahuasca. Pretreatment with ketanserin inhibited neurophysiological modifications, reduced the correlation between alpha and visual effects, and attenuated the intensity of the subjective experience. These findings suggest that despite the chemical complexity of ayahuasca, 5-HT2A activation plays a key role in the neurophysiological and visual effects of ayahuasca in humans.

Ayahuasca: Pharmacology, neuroscience and therapeutic potential.

Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) from P. viridis, plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties from B. caapi. Acute administration induces a transient modified state of consciousness characterized by introspection, visions, enhanced emotions and recollection of personal memories. A growing body of evidence suggests that ayahuasca may be useful to treat substance use disorders, anxiety and depression. Here we review the pharmacology and neuroscience of ayahuasca, and the potential psychological mechanisms underlying its therapeutic potential. We discuss recent findings indicating that ayahuasca intake increases certain mindfulness facets related to acceptance and to the ability to take a detached view of one's own thoughts and emotions. Based on the available evidence, we conclude that ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. We postulate that ayahuasca could be of use in the treatment of impulse-related, personality and substance use disorders and also in the handling of trauma. More research is needed to assess the full potential of ayahuasca in the treatment of these disorders.

Cultural Importance and Use of Medicinal Plants in the Shipibo-Conibo Native Community of Vencedor (Loreto) Peru

The main objectives of this research were to determine which medicinal plants are culturally most important for the native community of Vencedor as well as testing a new measure of the cultural importance of medicinal plants that can be used outside of this one particular case. Data were collected through participant observation, informal conversation, and semi-structured and structured interviews to 31 heads of family. According to the Cultural Significance for Conservation Index (CSCI) developed, significant species were Petiveria alliacea L., Jatropha gossypifolia L., Mansoa alliacea (Lam.) A.H.Gentry, Hura crepitans L., and Banisteriopsis caapi (Spruce ex Griseb.) C.V.Morton. Our index showed a significant correlation with the other indices considered in this paper. We conclude that CSCI is a good indicator of the cultural importance of medicinal plants and that it can be useful in cases where there is a need to recognize which culturally important plants are more vulnerable.

Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.

Ayahuasca is a hallucinogenic beverage that combines the action of the 5-HT2A/2C agonist N,N-dimethyltryptamine (DMT) from Psychotria viridis with the monoamine oxidase inhibitors (MAOIs) induced by beta-carbonyls from Banisteriopsis caapi. Previous investigations have highlighted the involvement of ayahuasca with the activation of brain regions known to be involved with episodic memory, contextual associations and emotional processing after ayahuasca ingestion. Moreover long term users show better performance in neuropsychological tests when tested in off-drug condition. This study evaluated the effects of long-term administration of ayahuasca on Morris water maze (MWM), fear conditioning and elevated plus maze (EPM) performance in rats. Behavior tests started 48h after the end of treatment. Freeze-dried ayahuasca doses of 120, 240 and 480 mg/kg were used, with water as the control. Long-term administration consisted of a daily oral dose for 30 days by gavage. The behavioral data indicated that long-term ayahuasca administration did not affect the performance of animals in MWM and EPM tasks. However the dose of 120 mg/kg increased the contextual conditioned fear response for both background and foreground fear conditioning. The tone conditioned response was not affected after long-term administration. In addition, the increase in the contextual fear response was maintained during the repeated sessions several weeks after training. Taken together, these data showed that long-term ayahuasca administration in rats can interfere with the contextual association of emotional events, which is in agreement with the fact that the beverage activates brain areas related to these processes.

Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?

Banisteriopsis caapi, a liana indigenous to the Amazon basin with metagnomigenic properties and possible anti-depressant effects is one of the natural sources of harmala alkaloids. A summary of early trials with extracts of Banisteriopsis caapi and Peganum harmala (from which harmine was first isolated) in the 1920s and 1930s on various forms of parkinsonism is given as well as a brief overview of the known pharmacological properties of harmine. Despite its earlier abandonment because of perceived weaker efficacy than solanaceous alkaloids like scopolamine and hyoscine we propose that harmine should be reconsidered as a potential rapidly acting anti-Parkinsonian agent.

Ayahuasca Alters Structural Parameters of the Rat Aorta.

Ayahuasca is a hallucinogenic brew traditionally used by Northwestern Amazonian indigenous groups for therapeutic purposes. It is prepared by the decoction of Banisteriopsis caapi with the leaves of Psychotria viridis. Banisteriopsis caapi contains β-carbolines that are inhibitors of monoamine oxidase and P. viris is rich in dimethyltryptamine, a 5-HT(1A/2A/2C) agonist. Acute ayahuasca administration produces moderate cardiovascular effects in healthy volunteers, but information regarding long-term use is lacking. This study investigated the effects of ayahuasca (2-4 mL/kg) in the rat aorta after acute and chronic (14 days) administration. Ayahuasca caused flattening and stretching of vascular smooth muscle cells and changes in the arrangement and distribution of collagen and elastic fibers. Chronic treatment with the higher dose significantly increased media thickness and the ratio of media thickness to lumen diameter. More research is needed on the cardiovascular function of long-term ayahuasca consumers.

Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death

Light microscopical examination of plant and fungal remains in the post mortem gut may be capable of demonstrating the ingestion of unexpected natural psychotropic materials. This is demonstrated here in a case in which a 'shaman' was accused of causing the death of a young man. The deceased had participated in a ceremony which involved the drinking of ayahuasca in order to induce a psychotropic experience. Ayahuasca is an infusion of Banisteriopsis caapi (ayahuasca vine), which produces a monoamine oxidase inhibitor, and one or more additional tropical plants, generally Psychotria viridis (chacruna) which produces dimethyltryptamine (DMT). The monoamine oxidase inhibitor prevents DMT from being broken down in the gut, so enabling its passage into the bloodstream and across the blood/brain barrier. Toxicological tests for DMT demonstrated the presence of this compound in the body. The deceased was reported to be in the habit of using Psilocybe semilanceata (liberty cap). This fungus (popularly called magic mushroom) contains psilocybin which is hydrolysed in the gut to psilocin; this compound mimics a serotonin uptake inhibitor, and also invokes psychotropic experiences. Microscopical examination established that the ileum and colon contained spores of Psilocybe and, in addition, pollen of Cannabis sativa and seeds of Papaver cf. somniferum (opium poppy). Both the plant species yield psychotropic substances. Palynological and mycological analysis of containers from the deceased person's dwelling also yielded abundant trace evidence of pertinent pollen and spores. The police had requested analysis for DMT but there was no screening for other psychotropic substances. Investigators were surprised that a mixture of hallucinogenic materials had been consumed by the deceased. The charge was modified from manslaughter to possession of a ‘Class A’ drug as the deceased had been consuming psychotropic substances not administered by the 'shaman'. Where death involving drugs from plants or fungi is suspected, microscopical examination of samples from the gut can provide a rapid and effective method for assessing, in a temporal context, the presence of ingested materials that may not have been previously suspected. The example presented here also demonstrates the need for caution in interpreting toxicological results where screening for unusual compounds has been limited.

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat

Ayahuasca, a psychoactive beverage used by indigenous and religious groups, is generally prepared by the coction of Psychotria viridis and Banisteriopsis caapi plants containing N,N-dimethyltryptamine (DMT) and β-carboline alkaloids, respectively. To investigate the acute toxicity of ayahuasca, the infusion was administered by gavage to female Wistar rats at doses of 30X and 50X the dose taken during a religious ritual, and the animals observed for 14 days. Behavioural functions were investigated one hour after dosing at 15X and 30X using the open field, elevated plus maze, and forced swimming tests. Neuronal activation (c-fos marked neurons) and toxicity (Fluoro-Jade B and Nissl/Cresyl staining) were investigated in the dorsal raphe nuclei (DRN), amygdaloid nucleus, and hippocampal formation brain areas of rats treated with a 30X ayahuasca dose. The actual lethal oral dose in female Wistar rats could not be determined in this study, but was shown to be higher than the 50X (which corresponds to 15.1mg/kg bw DMT). The ayahuasca and fluoxetine treated groups showed a significant decrease in locomotion in the open field and elevated plus-maze tests compared to controls. In the forced swimming test, ayahuasca treated animals swam more than controls, a behaviour that was not significant in the fluoxetine group. Treated animals showed higher neuronal activation in all brain areas involved in serotoninergic neurotransmission. Although this led to some brain injury, no permanent damage was detected. These results suggest that ayahuasca has antidepressant properties in Wistar female at high doses, an effect that should be further investigated.

Voltammetric determination of harmaline in natural food products using boron-doped diamond electrode

A novel analytical approach for the sensitive determination of a β-carboline alkaloid, harmaline, was developed using pulse voltammetric techniques with a boron-doped diamond electrode. Cyclic voltammetry showed two irreversible oxidation peaks at about +0.90 and +1.20V (vs. Ag/AgCl) in Britton–Robinson buffer solution at pH 5. Under optimized experimental conditions, differential pulse and square-wave voltammetry were elaborated for the determination of harmaline in a linear concentration range from 0.2 to 100.7 and from 0.4 to 104.5μmolL−1, respectively, with detection limits of 0.08 and 0.2μmolL−1, respectively. The practical feasibility of the developed method was demonstrated by quantification of harmaline in the extracts of natural food products such as Syrian rue (Peganum harmala, also known as esphant, harmal, yüzerlik) seeds, locally used as condiment and medicine in Turkey and the Near and Middle East, and the South American shamanic drink component Ayahuasca liane (Banisteriopsis caapi) with results in good agreement with those obtained by high-performance liquid chromatography as a reference method. The proposed sensor represents an effective electrochemical tool and inexpensive alternative for quality control analysis of food products containing harmaline.

New electrochemical method for the determination of β-carboline alkaloids, harmalol and harmine, in human urine samples and in Banisteriopsis caapi

In this paper a new electrochemical method for determination of the β-carboline alkaloids, harmalol and harmine, using differential pulse voltammetry is presented. Experimental parameters such as pH, scan rate, pulse amplitude and pulse time were optimized to characterize their electrochemical behavior and to find best analytical conditions. Thus, in the presence of ascorbic acid, uric acid, dopamine, the developed method exhibits excellent performance for the determination of harmalol and harmine for a linear concentration range between 1–50μM and 1–75μM with a detection limit of 0.6μM and 0.2μM, respectively. The proposed method was successfully applied for the determination of these alkaloids in a sample of an Ayahuasca liana (Banisteriopsis caapi) and in model human urine samples with good recoveries.